Douglass B. Given
Bay City Capital
Douglass Given is an Investment Partner and fund General Partner at Bay City Capital, a life sciences venture capital firm, and has been with the firm since 2000. He was formerly the Chief Technology Officer and Corporate Sr. Vice President of Mallinckrodt, Vice President of Schering Plough Research Institute, Vice President of Monsanto/GD Searle Research Laboratories, and Medical Advisor of Lilly Research Laboratories. He Chaired the Pharmaceutical Manufacturer Assoc, Combined Regulatory Affairs Committee. Dr. Given is Chairman of Arrowhead Research Inc, ARWR, and has been a board director of Schering Corp, Schering Essex, Sembiosys Genetics, SBS, Aksys Inc, AKYS, Chairman and founder of Via Pharmaceuticals, VIAP, a board director and CEO of NeoRx Corp, NERX, and board director and CEO of Progenitor Inc and Mercator Genetics, PGEN. He is Chairman, founder and CEO of Vivaldi BioSciences. He served on the Queensland Investment Corp business advisory board for the Queensland Bio Fund. Dr. Given Chaired the Visiting Committee at the University of Chicago Medical Center, Pritzker School of Medicine and Biological Sciences Division from 2007-2013 and remains a life member and Distinguished Alumni Awardee. Additional Advisory Board memberships of the University of Chicago include the Global Health Institute, Innovation Fund and Trustee Committee on Innovation. He received an MD (honors, AOA) and PhD (Virology) from the University of Chicago and an MBA from The Wharton School, University of Pennsylvania. He previously attended Wabash College and Colorado State University. He was a Clinical and Research fellow at Harvard Medical School and The Massachusetts General Hospital in Internal Medicine and Infectious Diseases, and Assistant Professor of Medicine and Attending Physician at Indiana University Medical School.